# DOXEPIN HYDROCHLORIDE
> **ANDA211618** · Abbreviated New Drug Application (Generic) · Sponsor: VELZEN PHARMA PVT · Approved 2021-03-01
## Drug
- **FDA Application Number:** ANDA211618
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXEPIN HYDROCHLORIDE
- **Generic name:** DOXEPIN HYDROCHLORIDE
- **Active ingredients:** DOXEPIN HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VELZEN PHARMA PVT
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2021-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211618)
---
*MORVS · CC0 1.0*